WA-SPIE
10.1.2024 20:46:32 CET | Business Wire | Press release
The Awards Committee of SPIE, the international society for optics and photonics, today announced the recipients of its prestigious annual awards. Honoring transformative advancements in a variety of professional areas — including medicine, astronomy, lithography, optical metrology, optical design, and community leadership — the Society's awards recognize technical accomplishments as well as committed service to SPIE and support of its organizational mission.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240110537408/en/
Akhlesh Lakhtakia, the 2024 recipient of the SPIE Gold Medal. (Photo: Business Wire)
SPIE Gold Medal: Akhlesh Lakhtakia
For pioneering research on electromagnetic fields in complex materials including isotropic chiral, bianisotropic, and composite materials, metamaterials, and nanomaterials.
SPIE President's Award: Katie Schwertz
For outstanding service to SPIE and the optics community, through work that advances optical systems design, engages students, and shares the excitement of optics with the public.
SPIE Directors' Award: Halina Rubinsztein-Dunlop
For pioneering research in optics and photonics, and for distinguished service to SPIE as a leading light in promoting educational programs and supporting women in science.
SPIE Mozi Award: Andrea Alù
For seminal contributions to the field of optical metamaterials as well as their applications for wavefront manipulation and enhancement of nonreciprocal and nonlinear phenomena.
SPIE Mozi Award: Teri W. Odom
For significant contributions to the field of nanophotonics and to the development of moiré photonics.
SPIE Britton Chance Award in Biomedical Optics: Gerard L. Coté
For transformative advances in both fundamental and translational optical research toward the diagnosis and monitoring of chronic and infectious diseases.
SPIE Biophotonics Technology Innovator Award: Ji-Xin Cheng
For the invention and commercialization of mid-infrared photothermal microscopy that allows highly sensitive dye-free bond-selective imaging of living cells and organisms.
SPIE Rudolf and Hilda Kingslake Award in Optical Design: David Shafer
For outstanding contributions to the field of optical design including DUV and EUV photolithographic scanner designs that define the current technological limit of the semiconductor industry.
SPIE Harrison H. Barrett Award in Medical Imaging: Kyle J. Myers
For fundamental contributions to the field of image science, with an emphasis on the role of science in regulatory evaluations of imaging methods.
SPIE Harold E. Edgerton Award in High-Speed Optics: Clara Saraceno
For groundbreaking contributions to the development of ultrafast high-power lasers and laser-driven THz sources.
SPIE Dennis Gabor Award in Diffractive Optics: Jürgen Czarske
For significant contributions to the development of digital holography, and related techniques for biomedicine, fiber communication, imaging, information processing, and laser metrology.
SPIE A.E. Conrady Award in Optical Engineering: Thomas U. Kampe
For industry-recognized leadership in optical engineering, design, and development – including critical Earth-monitoring instruments – as well as for mentoring the next generation of optical engineers.
SPIE G. G. Stokes Award in Optical Polarization: Curtis R. Menyuk
For pioneering studies of linear and nonlinear polarization effects in guided-wave photonics which have impacted basic science, telecommunications systems, lasers, and many other photonics-based technologies.
SPIE Chandra S. Vikram Award in Optical Metrology: Anand Asundi
For numerous contributions to coherent optical metrology and sensing, with special attention to digital technologies.
SPIE Frits Zernike Award for Microlithography: Richard Sandstrom
For leadership in the development of lithographic-grade lasers and EUV light sources.
SPIE Diversity Outreach Award: Preeti Jagadev
For excellence in promoting and advocating diversity, equity, and inclusion in STEM.
SPIE Maria Goeppert Mayer Award in Photonics: Iam-Choon Khoo
For foundational contributions to linear and nonlinear optical properties of liquid crystals and their applications in wide-ranging, wave-mixing, and self-action effects.
SPIE Maiman Laser Award: Anne L’Huillier
For the discovery of high harmonic generation in gases, and contributions to developments in attoscience.
SPIE María J. Yzuel Educator Award: Mary G. Turner
For a lifetime of dedication to the teaching of optical design, and for services to the optics community.
SPIE Aden and Marjorie Meinel Technology Achievement Award: M. Saif Islam
For highly impactful innovations in ultra-fast and highly efficient photodetectors enabled by photon-trapping structures.
The complete listing of the SPIE Society Awards and recipients is available here.
About SPIE
SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, SPIE has contributed more than $24 million to the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development. www.spie.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240110537408/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom